XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.2
Collaborative Arrangements - Bayer AG (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sales $ 15,806,000,000 $ 16,112,000,000 $ 31,335,000,000 $ 31,887,000,000  
Cost of sales 3,557,000,000 3,745,000,000 6,976,000,000 7,285,000,000  
Selling, general and administrative 2,649,000,000 2,739,000,000 5,202,000,000 5,221,000,000  
Research and development 4,048,000,000 3,500,000,000 7,669,000,000 7,492,000,000  
Other current assets 37,065,000,000   37,065,000,000   $ 38,782,000,000
Accrued and other current liabilities 14,502,000,000   14,502,000,000   15,694,000,000
Adempas | Licenses and Other          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Finite-lived intangible assets 348,000,000   348,000,000    
Verquvo | Licenses and Other          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Finite-lived intangible assets 43,000,000   43,000,000    
Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Eligible future contingent sales-based milestone payments (up to) 0   0    
Revenue from collaborative arrangement 123,000,000 106,000,000 229,000,000 203,000,000  
Sales 214,000,000 187,000,000 397,000,000 361,000,000  
Cost of sales 61,000,000 61,000,000 120,000,000 123,000,000  
Selling, general and administrative 29,000,000 26,000,000 58,000,000 59,000,000  
Research and development 20,000,000 28,000,000 43,000,000 55,000,000  
Other current assets 173,000,000   173,000,000   160,000,000
Accrued and other current liabilities 88,000,000   88,000,000   $ 82,000,000
Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Adempas          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sales 80,000,000 72,000,000 147,000,000 142,000,000  
Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Verquvo          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sales $ 11,000,000 $ 9,000,000 $ 21,000,000 $ 16,000,000